Raiffeisen Bank International’s Cabaletta Bio CABA Stock Holding History

Raiffeisen Bank International’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	430,000 -20,000	-4%	-$65.8K	0.02%	384
2026 Q1	$1.11M	Hold	450,000	–	–	0.02%	377
2025 Q4	$968K	Buy	450,000 +100,000	+29%	+$248K	0.01%	353
2025 Q3	$833K	Buy	350,000 +50,000	+17%	+$85.8K	0.01%	359
2025 Q2	$531K	Hold	300,000	–	–	0.01%	368
2025 Q1	$465K	Buy	300,000 +80,000	+36%	+$170K	0.01%	377
2024 Q4	$493K	Buy	+220,000	New	+$772K	0.01%	358

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Raiffeisen Bank International's CABA Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Cabaletta Bio (CABA) stake by 4.4% in Q2 2026, selling an estimated $65.8K and leaving 430,000 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #384.

Raiffeisen Bank International first reported a position in CABA in Q4 2024 and has held it in 7 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Raiffeisen Bank International held 430,000 shares of Cabaletta Bio worth $1.34M as of Q2 2026.
Raiffeisen Bank International sold 20,000 Cabaletta Bio shares in Q2 2026, an estimated $65.8K.
Cabaletta Bio made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #384 holding.
Raiffeisen Bank International first reported a position in Cabaletta Bio in Q4 2024 and has held it in 7 quarters since.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.